핵의학 방사성 의약품 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별
Radiopharmaceuticals in Nuclear Medicine Market, By Product Type, By Application, By End User, By Geography
상품코드
:
1672927
리서치사
:
Coherent Market Insights
발행일
:
2025년 02월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계 핵의학 방사성 의약품 시장은 2025년 77억 2,000만 달러, 2032년에는 138억 5,000만 달러에 달할 것으로 예측되며, 2025-2032년 연평균 8.7%의 성장률(CAGR)을 나타낼 것으로 예상됩니다.
| 보고 범위 |
보고서 상세 내용 |
| 기준 연도 |
2024년 |
2025년 시장 규모 |
77억 2,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
8.70% |
2032년 금액 예측 |
138억 5,000만 달러 |
그림. 2025년 지역별 핵의학 방사성 의약품 시장 점유율(%)
방사성의약품은 진단과 치료 목적으로 핵의학에서 사용되는 방사성 의약품입니다. 방사성의약품은 체내에 도입된 방사성 추적자로부터 감마선 등의 핵 방사선을 방출함으로써 의료용 영상진단 기술에서 중요한 역할을 하고 있습니다. 방사성의약품은 방사성 동위원소를 단클론 항체와 같은 생리활성 의약품 화합물에 결합시킨 것으로 조직, 장기, 세포를 선택적으로 표적화하여 조직, 장기, 세포를 선택적으로 표적화합니다. 스캔 중 감마 카메라와의 상호작용을 통해 의사는 비침습적으로 대사, 생리적, 해부학적 세부 사항에 대한 기능적 통찰력을 얻을 수 있습니다. 만성 질환의 유병률 증가, 암 및 심장 질환에 취약한 노인 증가, 방사성 추적자의 기술 발전은 방사성의약품 시장의 성장을 가속할 수 있습니다.
시장 역학
질병의 조기 진단에 대한 수요의 급증, 유리한 상환 정책, 의료비 지출 증가, 핵의학 치료의 이점에 대한 인식 등이 핵의료용 방사성의약품 시장을 견인할 것입니다. 그러나 방사성 추적자의 반감기가 짧아 현장 제조 설비가 필요하고, 장비 설치 및 유지보수 비용이 높다는 점은 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 연구개발 협력을 통해 신경학, 희귀질환, 개인맞춤형 의료를 위한 새로운 방사성 추적자를 개발하는 것은 성장 기회를 가져올 수 있습니다. 또한, 의약품 개발 및 표적 방사선 치료의 신흥 시장 개척도 시장 성장을 가속할 수 있습니다.
본 조사의 주요 특징
- 세계의 핵의학 분야 방사성의약품(방사성의약품) 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 파악하고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
- 본 보고서에서는 세계 핵의학 방사성 의약품 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등의 파라미터를 기준으로 정리하여 전해드립니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 핵의학 방사성 의약품 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 핵의학 방사성 의약품 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 시장 동향
- 규제 시나리오
- 인수와 제휴 시나리오
- 자금조달과 투자
- PEST 분석
- Porter의 Five Forces 분석
제4장 세계의 핵의학 방사성 의약품 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- 전체적인 영향
- 정부 이니셔티브
- 시장에 대한 COVID-19의 영향
제5장 세계의 핵의학 방사성 의약품 시장, 제품 유형별, 2020-2032년(10억 달러)
- 서론
- 핵의료 진단
- SPECT 방사성 의약품
- PET 방사성 의약품
- 핵의료 치료
제6장 세계의 핵의학 방사성 의약품 시장, 용도별, 2020-2032년(10억 달러)
제7장 세계의 핵의학 방사성 의약품 시장, 최종사용자별, 2020-2032년(10억 달러)
- 서론
- 병원
- 외래수술센터(ASC)
- 전문 클리닉
- 진단센터
- 기타
제8장 세계의 핵의학 방사성 의약품 시장, 지역별, 2020-2032년(10억 달러)
- 서론
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제9장 경쟁 구도
- 기업 개요
- Progenics Pharmaceuticals, Inc.
- NorthStar Medical Radioisotopes LLC
- Curium Pharma
- Life Molecular Imaging
- Lantheus Holdings, Inc.
- Cardinal Health, Inc.
- General Electric Company
- Bracco SpA
- Bayer AG
- GE Healthcare
- Jubilant Pharmova Limited
- Eckert & Ziegler
- Mallinckrodt
- NTP Radioisotopes SOC Ltd.
- Telix Pharmaceuticals, Inc.
- Nordic Nanovector
- Y-mAbs Therapeutics, Inc.
- Siemens Healthineers AG
제10장 애널리스트 추천 사항
- 융성과 쇠퇴
- Coherent Opportunity Map
제11장 참고 문헌과 조사 방법
LSH
영문 목차
Global Radiopharmaceuticals in Nuclear Medicine Market is estimated to be valued at USD 7.72 Bn in 2025 and is expected to reach USD 13.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 7.72 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
8.70% |
2032 Value Projection: |
USD 13.85 Bn |
Figure. Radiopharmaceuticals In Nuclear Medicine Market Share (%), By Region 2025
Radiopharmaceuticals are radioactive drugs used in nuclear medicine for both diagnostics and therapeutics purposes. These play a crucial role in medical imaging techniques through emission of nuclear radiation such as gamma rays from radioactive tracers introduced into the body. Radiopharmaceuticals consist of radioactive isotopes bonded to bioactive pharmaceutical compounds like monoclonal antibodies to selectively target tissues, organs or cells. On interaction with gamma cameras during scans, these help physicians gain functional insights into metabolic, physiological and anatomical details non-invasively. Rising prevalence of chronic diseases, growing geriatric population susceptible to cancer and cardiac ailments and technological advancements in radiotracers can drive the growth of radiopharmaceuticals market.
Market Dynamics:
Surging demand for early disease diagnosis, favorable reimbursement policies, increasing healthcare expenditure, and awareness about benefits of nuclear medicine procedures can drive the radiopharmaceuticals in nuclear medicine market. However, short half-lives of radiotracers requiring on-site production facilities and high installation and maintenance costs of equipment can hamper the market growth. Developing new radiotracers for neurology, rare diseases and personalized medicine through R&D collaborations can offer growth opportunities. Emerging applications in drug development and targeted radiotherapy can also drive the market growth.
Key Features of the Study:
- This report provides in-depth analysis of the global radiopharmaceuticals in nuclear medicine market, and provides market size (USD billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global radiopharmaceuticals in nuclear medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GE Healthcare, Bracco Imaging S.p.A., Lantheus Medical Imaging Inc., Bayer AG, Novartis AG (Advanced Accelerator Applications), Nordion Inc., and Jubilant DraxImage Inc. dba Jubilant Radiopharma
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global radiopharmaceuticals in nuclear medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiopharmaceuticals in nuclear medicine market
Detailed Segmentation-
- By Product Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- PET Radiopharmaceuticals
- Therapeutic Nuclear Medicine
- By Application
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Others
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Diagnostic Centers
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Progenics Pharmaceuticals, Inc.
- NorthStar Medical Radioisotopes LLC
- Curium Pharma
- Life Molecular Imaging
- Lantheus Holdings, Inc.
- Cardinal Health, Inc.
- General Electric Company
- Bracco S.p.A.
- Bayer AG
- GE Healthcare
- Jubilant Pharmova Limited
- Eckert & Ziegler
- Mallinckrodt
- NTP Radioisotopes SOC Ltd.
- Telix Pharmaceuticals, Inc.
- Nordic Nanovector
- Y-mAbs Therapeutics, Inc.
- Siemens Healthineers AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Radiopharmaceuticals in Nuclear Medicine Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Radiopharmaceuticals in Nuclear Medicine Market, By Product Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Diagnostic Nuclear Medicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- SPECT Radiopharmaceuticals
- PET Radiopharmaceuticals
- Therapeutic Nuclear Medicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Radiopharmaceuticals in Nuclear Medicine Market, By Application, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Endocrinology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Radiopharmaceuticals in Nuclear Medicine Market, By End User, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Radiopharmaceuticals in Nuclear Medicine Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Progenics Pharmaceuticals, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NorthStar Medical Radioisotopes LLC
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Curium Pharma
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Life Molecular Imaging
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lantheus Holdings, Inc.
- Cardinal Health, Inc.
- General Electric Company
- Bracco S.p.A.
- Bayer AG
- GE Healthcare
- Jubilant Pharmova Limited
- Eckert & Ziegler
- Mallinckrodt
- NTP Radioisotopes SOC Ltd.
- Telix Pharmaceuticals, Inc.
- Nordic Nanovector
- Y-mAbs Therapeutics, Inc.
- Siemens Healthineers AG
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
관련자료
